|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/444 | (2006.01) |
| A61K 31/444 | (2013.01) | ||
| A61K 31/5513 | (2006.01) | ||
| A61K 31/5513 | (2013.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 47/38 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 9/1611 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 9/1641 | (2013.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61P 25/30 | (2006.01) | ||
| A61K 9/167 | (2013.01) | ||
| A61K 9/1682 | (2013.01) | ||
| A61K 9/2886 | (2013.01) | ||
| A61K 9/4808 | (2013.01) | ||
| A61P 25/30 | (2018.01) |
| (11) | Patento numeris | 3592350 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18764574.2 |
| Europos patento paraiškos padavimo data | 2018-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-03-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/021939 |
| Data | 2018-03-12 |
| (87) | Numeris | WO 2018/165649 |
| Data | 2018-09-13 |
| (30) | Numeris | Data | Šalis |
| 201762469798 P | 2017-03-10 | US |
| (72) |
STRAUB, Julie , US
DUVVURI, Muralikrishna , US
VED, Parag, M. , US
REHLAENDER, Bruce , US
BREAUX, Jay , US
VADINO, Winston, A. , US
BORAH, Kripanath , US
GLOFF, Carol , US
|
| (73) |
Embera NeuroTherapeutics, Inc. ,
2 Main Street, Building 17
Suite 302P, Biddeford, ME 04005,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING METYRAPONE AND OXAZEPAM AND USES THEREOF |
| PHARMACEUTICAL COMPOSITIONS COMPRISING METYRAPONE AND OXAZEPAM AND USES THEREOF |